2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Coloring Agents: new trials by email Literature Review of Coloring Agents trials Research Report on Coloring Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Near-infrared Fluorescence Lymphatic Imaging Assessment of Lymphatic Response to Pneumatic Back/Neck Lymphatic Drainage Delivered by a Pneumatic Manual Lymphatic Drainage Device Indocyanine green (ICG) dye, NIRF-LI imaging, Neuroglide pad - Neck Pain, Back Pain | Phase 1 | Completed | The University of Texas Health Science Center, Houston | 4 | 2023-08-29 | 2023-12-14 |
| Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation therapeutic allogeneic lymphocytes, aldesleukin, peripheral blood stem cell transplantation - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Phase 1 / Phase 2 | Completed | Fred Hutchinson Cancer Center | 37 | 2002-09-01 | 2017-03-29 |
Anemia, Refractory, with Excess of Blasts (1) · Back Pain (1) · Congenital Abnormalities (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myelomonocytic, Chronic (1) · Neck Pain (1) · Polycythemia Vera (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Thrombocythemia, Essential (1)
Fred Hutchinson Cancer Center (1) · The University of Texas Health Science Center, Houston (1)
United States (2)
Melissa B Aldrich, PhD, MBA (1) · Merav Bar (1)
P01CA018029 (1)